Journals / Turkish Journal of Medical Sciences / 2006 / Cilt: 36 - Sayı: 5

Carriage of Mobilizable Plasmid-Mediated b-Lactamase Gene in Ampicillin-Resistant Escherichia coli Strains with Origin of Normal Fecal Flora

Pages
307–314
Publication Date
2006-05-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: These results indicate that commensal E. coli strains carrying b-lactamase gene in the bowel environment could retain resistance determinants on small-sized resistance plasmids (R plasmids) and become a potential reservoir for resistance genes in the community, even in the absence of recent antibiotic consumption.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to investigate the carriage of b-lactamase genes in ampicillin-resistant (Ampr) Escherichia coli (E. coli) isolates from human normal fecal flora.
📊
Key Findings & Data:Methods: Ten Ampr E. coli strains isolated from the stool samples of 21 healthy persons with no antibiotic use during at least three months were screened for TEM-, SHV-, or OXA-type b-lactamase genes by polymerase chain reaction (PCR).
💡
Conclusion & Impact:Conclusions: These results indicate that commensal E. coli strains carrying b-lactamase gene in the bowel environment could retain resistance determinants on small-sized resistance plasmids (R plasmids) and become a potential reservoir for resistance genes in the community, even in the absence of recent antibiotic consumption.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Fecal flora · ampicillin-resistant Escherichia coli · mobilizable b-lactamase gene

Abstract

Aim: The aim of this study was to investigate the carriage of b-lactamase genes in ampicillin-resistant (Ampr) Escherichia coli (E. coli) isolates from human normal fecal flora. Methods: Ten Ampr E. coli strains isolated from the stool samples of 21 healthy persons with no antibiotic use during at least three months were screened for TEM-, SHV-, or OXA-type b-lactamase genes by polymerase chain reaction (PCR). The susceptibility of the strains to antibiotics was determined by disk diffusion method, and minimum inhibitory concentration (MIC) of ampicillin to the strains was determined by agar dilution method. Plasmid transfer assays were performed by broth mating technique. Plasmid DNA was isolated by alkaline lysis method. Digoxigenin-labeled TEM-1 probe was used in hybridization assays. Results: Two of 10 strains were found to be carrier for only TEM-type b-lactamase gene (blaTEM) by PCR, and their resistances to ampicillin were conjugatively transferred to a recombinant E. coli K-12 strain C600. MIC of ampicillin to two representative strains and their transconjugants was detected as >512 µg/ml. Moreover, b-lactamase inhibitor resistance was also observed in these two strains and their transconjugants. Digoxigenin-labeled TEM-1 DNA probe was hybridized to some non-conjugative but mobilizable plasmid DNAs purified from two of the TEM-gene-carrying organisms. Conclusions: These results indicate that commensal E. coli strains carrying b-lactamase gene in the bowel environment could retain resistance determinants on small-sized resistance plasmids (R plasmids) and become a potential reservoir for resistance genes in the community, even in the absence of recent antibiotic consumption.

Özet

Aim: The aim of this study was to investigate the carriage of b-lactamase genes in ampicillin-resistant (Ampr) Escherichia coli (E. coli) isolates from human normal fecal flora. Methods: Ten Ampr E. coli strains isolated from the stool samples of 21 healthy persons with no antibiotic use during at least three months were screened for TEM-, SHV-, or OXA-type b-lactamase genes by polymerase chain reaction (PCR). The susceptibility of the strains to antibiotics was determined by disk diffusion method, and minimum inhibitory concentration (MIC) of ampicillin to the strains was determined by agar dilution method. Plasmid transfer assays were performed by broth mating technique. Plasmid DNA was isolated by alkaline lysis method. Digoxigenin-labeled TEM-1 probe was used in hybridization assays. Results: Two of 10 strains were found to be carrier for only TEM-type b-lactamase gene (blaTEM) by PCR, and their resistances to ampicillin were conjugatively transferred to a recombinant E. coli K-12 strain C600. MIC of ampicillin to two representative strains and their transconjugants was detected as >512 µg/ml. Moreover, b-lactamase inhibitor resistance was also observed in these two strains and their transconjugants. Digoxigenin-labeled TEM-1 DNA probe was hybridized to some non-conjugative but mobilizable plasmid DNAs purified from two of the TEM-gene-carrying organisms. Conclusions: These results indicate that commensal E. coli strains carrying b-lactamase gene in the bowel environment could retain resistance determinants on small-sized resistance plasmids (R plasmids) and become a potential reservoir for resistance genes in the community, even in the absence of recent antibiotic consumption.

🔖

Cite This Article

ÖZGÜMÜŞ, O. B. (2006). Carriage of Mobilizable Plasmid-Mediated b-Lactamase Gene in Ampicillin-Resistant Escherichia coli Strains with Origin of Normal Fecal Flora. Turkish Journal of Medical Sciences, Cilt: 36 - Sayı: 5, 307–314. https://ajindex.com/articles/723676

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Calva JJ, Sifuentes-Osornio J, Ceron C. Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico. Antimicrob Agents Chemother 1996; 40: 1699–1702
  2. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. Br Med J 1998; 317: 647–650
  3. Komatsu M, Aihara M, Shimakawa K, Yamanaka T, Matsuo S. Detection of extended spectrum β-lactamases producing Enterobacteriaceae in feces. Kansenshogaku Zasshi 2000; 74: 250–258
  4. Shanahan PMA, Thomson CJ, Amyes SGB. β-lactam resistance in normal faecal flora from South Africa. Epidemiol Infect 1995; 115: 243–253
  5. Franiczek R, Sobieszczanska B, Grabowski M, Mowszet K, Pytrus T. Occurrence of extended-spectrum β-lactamases among Escherichia coli isolates from hospitalized and healthy children. Folia Microbiol 2003; 48: 243–247
  6. Infante B, Grape M, Larsson M, Kristiansson C, Pallecchi L, Rossolini GM et al. Acquired sulphonamide resistance genes in faecal Escherichia coli from healthy children in Bolivia and Peru. Int J Antimicrob Agents 2005; 25: 308–312
  7. Levin BR, Lipsitch M, Perrot V, Schrag S, Antia R, Simonsen L et al. The population genetics of antibiotic resistance. Clin Infect Dis 1997; 24: S9–16
  8. Levy S, Marshall B, Schleuderberg S, Rowe B, Davis J. High frequency of antibiotic resistance in human fecal flora. Antimicrob Agents Chemother 1988; 32: 1801–1806
  9. Österblad M, Hakanen A, Manninen R, Leistevuo T, Peltonen R, Meurman O et al. A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother 2000; 44: 1471–1484
  10. Komatsu M, Aihara M, Shimakawa K, Yamanaka T, Matsuo S. Detection of extended spectrum β-lactamases producing Enterobacteriaceae in feces. Kansenshogaku Zasshi 2000; 74: 250–258
  11. Baquero F, Negri MC, Morosini MI, Blazquez J. Antibioticselective environments. Clin Infect Dis 1998, 27(Suppl. 1): S5–11
  12. Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–584
  13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. M2-A6 Approval Standard. Wayne, Pa: NCCLS, 1997
  14. Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST. Bergey’s Manual of Determinative Bacteriology. 9th ed. Baltimore: Williams and Wilkins, 1994
  15. Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ. Manual of clinical microbiology. 5th ed. Washington (DC): Americ